WG
CHRS icon

Wealth Group’s Coherus Oncology CHRS Stock Holding History

Wealth Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,195
Closed -$24K – 110
2026
Q1 		$24K Hold
14,195
– – 0.02% 87
2025
Q4 		$20K Buy
+14,195
New +$20.7K 0.02% 83
2025
Q2 		$29K Sell
39,195
-13,000
-25% -$11.2K 0.03% 88
2025
Q1 		$42K Hold
52,195
– – 0.03% 155
2024
Q4 		$72K Hold
52,195
– – 0.05% 158
2024
Q3 		$54K Sell
52,195
-282
-0.5% -$387 0.04% 151
2024
Q2 		$94K Buy
+52,477
New +$106K 0.07% 146

Other funds holding CHRS

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
CWS
Confluence Wealth Services Mcmurray, Pennsylvania $3.5B AUM 22.08% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Wealth Group's CHRS Position: Q2 2026 in Review

Wealth Group sold out of Coherus Oncology (CHRS) in Q2 2026, closing a stake of 14,195 shares — an estimated $24K sold.

Wealth Group first reported a position in CHRS in Q2 2024 and held it in 7 quarters. The position peaked at $94K in Q2 2024. 20 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Wealth Group reported no remaining Coherus Oncology position as of Q2 2026 after selling out during the quarter.
  • Wealth Group sold 14,195 Coherus Oncology shares in Q2 2026, an estimated $24K.
  • Wealth Group first reported a position in Coherus Oncology in Q2 2024 and held it in 7 quarters.
  • Wealth Group's Coherus Oncology position peaked at $94K in Q2 2024.
  • 20 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.